CD4 and primary cutaneous T-cell non-Hodgkin lymphoma: TOX expression has been analyzed in cutaneous T-cell lymphomas (CTCL) and noticed that its expression is not tumor-specific or restricted to CD4+ CD8- phenotype (49).